EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Zidovudine for chemoprophylaxis after occupational exposure to HIV-infected blood: an economic evaluation


Clinical Infectious Diseases 14(4): 822-830
Zidovudine for chemoprophylaxis after occupational exposure to HIV-infected blood: an economic evaluation
The costs were estimated of 3 strategies for the management of health-care workers after needlestick injury: (A) continue therapy with zidovudine for 4 weeks if the patient tests seropositive for HIV (2) or discontinue therapy and follow up if seronegative (B) as for (A) except that zidovudine is not offered (C) patients blood is not tested and zidovudine is not offered.


Accession: 002549079

PMID: 1576276

DOI: 10.1093/clinids/14.4.822



Related references

Zidovudine for occupational exposure to hiv infected blood an economic evaluation. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 31: 262, 1991

Zidovudine use after occupational exposure to hiv infected blood. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 434b, 1991

Zidovudine azt use after occupational exposure to hiv infected blood. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sc766, 1990

Occupational exposure to HIV and zidovudine chemoprophylaxis. Anaesthesia 45(11): 989-990, 1990

Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Annals of Internal Medicine 118(12): 913-919, 1993

Safety of zidovudine zdv as post exposure chemoprophylaxis to healthcare workers hcw after occupational exposures to hiv. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : c267, 1992

Safety of zidovudine administered as post-exposure chemoprophylaxis to healthcare workers sustaining occupational exposures to HIV. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33(0): 324, 1993

Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group. Annals of Internal Medicine 118(12): 913-919, 1993

Occupational percutaneous exposure to blood a decision analysis on the role of zidovudine prophylaxis. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract 3081, 1990

Assessment of risk for occupational hiv 1 infection in health care workers hcw and follow up of hcw electing zidovudine azt chemoprophylaxis. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Thc 599, 1990